Advisor Net Financial, Inc Biogen Inc. Transaction History

Advisor Net Financial, Inc

$1.27 Billion
Q3 2024

A detailed history of Advisor Net Financial, Inc transactions in Biogen Inc. stock. As of the latest transaction made, Advisor Net Financial, Inc holds 76 shares of BIIB stock, worth $12,147. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 40 90.0%

Holding current value

$12,147

Previous $9,000 55.56%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$189.07 - $236.8 $6,806 - $8,524	36 Added 90.0%	76 $14,000
Q2 2024 Jul 16, 2024	BUY	$190.52 - $236.72 $3,048 - $3,787	16 Added 66.67%	40 $9,000
Q1 2024 Apr 12, 2024	SELL	$212.02 - $267.71 $5,512 - $6,960	-26 Reduced 52.0%	24 $5,000
Q4 2023 Jan 19, 2024	SELL	$222.59 - $267.94 $13,132 - $15,808	-59 Reduced 54.13%	50 $12,000
Q3 2023 Oct 12, 2023	SELL	$253.3 - $285.89 $106,132 - $119,787	-419 Reduced 79.36%	109 $28,000
Q2 2023 Jul 14, 2023	SELL	$275.25 - $318.06 $1,376 - $1,590	-5 Reduced 0.94%	528 $150,000
Q1 2023 Apr 28, 2023	BUY	$256.56 - $292.34 $15,137 - $17,248	59 Added 12.45%	533 $148,000
Q4 2022 Jan 13, 2023	SELL	$252.44 - $306.72 $16,913 - $20,550	-67 Reduced 12.38%	474 $0
Q3 2022 Oct 04, 2022	SELL	$194.69 - $268.46 $19,274 - $26,577	-99 Reduced 15.47%	541 $144,000
Q2 2022 Jul 07, 2022	BUY	$187.54 - $223.02 $750 - $892	4 Added 0.63%	640 $131,000
Q1 2022 Apr 14, 2022	SELL	$193.77 - $244.14 $17,826 - $22,460	-92 Reduced 12.64%	636 $134,000
Q4 2021 Jan 19, 2022	SELL	$223.92 - $287.77 $23,287 - $29,928	-104 Reduced 12.5%	728 $175,000
Q3 2021 Oct 15, 2021	BUY	$282.99 - $369.05 $6,225 - $8,119	22 Added 2.72%	832 $235,000
Q2 2021 Jul 06, 2021	SELL	$259.0 - $414.71 $56,462 - $90,406	-218 Reduced 21.21%	810 $280,000
Q1 2021 Apr 14, 2021	BUY	$242.95 - $284.63 $97,180 - $113,852	400 Added 63.69%	1,028 $288,000
Q4 2020 Feb 04, 2021	SELL	$236.26 - $355.63 $70,878 - $106,689	-300 Reduced 32.33%	628 $154,000
Q3 2020 Nov 06, 2020	BUY	$264.77 - $305.71 $26,477 - $30,570	100 Added 12.08%	928 $263,000
Q2 2020 Aug 26, 2020	BUY	$258.66 - $342.55 $82,771 - $109,616	320 Added 62.99%	828 $222,000
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $45,704 - $57,976	-170 Reduced 25.07%	508 $161,000
Q3 2019 Oct 23, 2019	BUY	$217.44 - $243.88 $57,186 - $64,140	263 Added 63.37%	678 $158,000
Q2 2019 Jul 15, 2019	SELL	$219.29 - $241.72 $12,718 - $14,019	-58 Reduced 12.26%	415 $97,000
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $54,177 - $84,740	250 Added 112.11%	473 $112,000
Q4 2018 Feb 08, 2019	BUY	$278.5 - $352.75 $20,330 - $25,750	73 Added 48.67%	223 $67,000
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $2,641 - $3,454	-9 Reduced 5.66%	150 $53,000
Q2 2018 Jul 27, 2018	BUY	$257.52 - $306.91 $5,407 - $6,445	21 Added 15.22%	159 $46,000
Q1 2018 May 08, 2018	SELL	$260.13 - $367.91 $76,738 - $108,533	-295 Reduced 68.13%	138 $38,000
Q4 2017 Feb 27, 2018	BUY	$307.64 - $344.58 $133,208 - $149,203	433	433 $138,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.

Account

Advisor Net Financial, Inc Biogen Inc. Transaction History